Crescent Biopharma

CBIONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$625.504 M

$16.84 +2.50%

Close of 7 Aug 2026

Revenue

$10.8M

#3159 by revenue

Earnings

$153.9K

#2452 by earnings

Shares outstanding

37,143,940

Latest filing cover page

P/E ratio

4063.2

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#192Immix BiopharmaIMMX$678.4M
#193Faeth TherapeuticsFTH$630.2M
#194Crescent BiopharmaCBIO$625.5M
#195Nuvectis PharmaNVCT$617.4M
#196ARS PharmaceuticalsSPRY$611.7M

Where these numbers come from

Share counts and financials for Crescent Biopharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.